Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
| Details |  |
|---|---|
| Related links |  |
| Search |  |
Rchr
J-GLOBAL ID：200901046723551070
Update date: Dec. 18, 2024 Fukao Hideharu
フカオ ヒデハル | Fukao Hideharu
ClipsMISC (163)
- H Fukao, Y Ijiri, M Miura, M Hashimoto, T Yamashita, C Fukunaga, K Oiwa, Y Kawai, M Suwa, J Yamamoto. Effect of trans-resveratrol on the thrombogenicity and atherogenicity in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. BLOOD COAGULATION & FIBRINOLYSIS. 2004. 15. 6. 441-446
- S Ueshima, H Fukao, K Okada, O Matsuo. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells. THROMBOSIS RESEARCH. 2004. 113. 1. 41-49
- M Akao, S Ueshima, K Okada, H Fukao, T Seki, T Ariga, O Matsuo. Cellular density regulation of plasminogen gene expression in mouse hepatocytes. LIFE SCIENCES. 2003. 72. 15. 1695-1704
- Shigeru Ueshima, Hideharu Fukao, Kiyotaka Okada, Osamu Matsuo. Suppression of the release of type-1 plasminogen activator inhibitor from human vascular endothelial cells by Hawaii deep sea water. Pathophysiology. 2003. 9. 2. 103-109
- Vascular Cell Functions in French Paradox. Bulletin of Kurashiki Sakuyo University & Sakuyo Junior College. 2002. 35. 2. 45-77
- t-PA受容体の発現による血管内皮細胞の抗血栓性機能調節. 成人病と生活習慣病. 2002. 32(10), 1369-1372
- Loss of placental growth factor protects mice against vascular permeability in pathological conditions. Biochem. Biophys. Res. Commun. 2002. 295(2), 428-434
- Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo. Thromb. Haemost. 2002. 87(6), 1069-1074
- t-PA受容体の分子クローニング、細胞内伝達系および生物学的意義の解析. 平成11-12年度科学研究費補助金基盤研究(C)(2)研究成果報告書. 2002
- t-PA受容体の発現による血管内皮細胞の抗血栓性機能調節. 財団法人三井生命厚生事業団第33回医学研究助成研究成果報告書. 2002
- Vascular cell functions in French paradox. Bulletin of Kurashiki Sakuyo University & Sakuyo Junior College. 2002. 35. 2. 45-77
- Loss of placental growth factor protects mice against vascular permeability in pathological conditions. Biochem. Biophys. Res. Commun. 2002. 295. 2. 428-434
- Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo. Thromb. Haemost. 2002. 87(6), 1069-1074
- t-PA遺伝子治療に関する最近の文献紹介. 日本血栓止血学会誌. 2001. 12(1), 85
- 線溶系因子による血管平滑筋細胞の生物学的機能発現の解析. 平成11-12年度科学研究費補助金基盤研究(C)(2)研究成果報告書. 2001
- Analysis of complex formation between plasmin(ogen) and staphylokinase or streptokinase. Arc. Biochem. Biophys. 2001. 393(2), 339-341
- Enahancement of t-PA-mediated plasminogen activation on surface of endothelial cells by t-PA receptor. Blood Coagl. Fibrinol. 2001. 12(5), 413-414
- Analysis of complex formation between plasmin(ogen) and staphylokinase or streptokinase. Arc. Biochem. Biophys. 2001. 393(2), 339-341
- Enahancement of t-PA-mediated plasminogen activation on surface of endothelial cells by t-PA receptor. Blood Coagl. Fibrinol. 2001. 12(5), 413-414
- S Ueshima, H Fukao, K Okada, O Matsuo. The effect of argatroban on injured endothelial cells by thrombin. BLOOD COAGULATION & FIBRINOLYSIS. 2000. 11. 7. 631-639
Return to Previous Page
